ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382049 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382049; 2) Community: the network communities that were significantly associated with the response to NSC 382049; 3) Molecule: the relationships between components within communities and NSC 382049; 4) MDR: the compounds that were significantly associated with the NSC 382049.

NSC Compound Enrichment Correlation
NSC 369327 ELSAMICIN 0.0176693828663435 0.23200596
NSC 685189 Null 0.0176693828663438 0.28039969
NSC 720992 Null 0.0176693828663438 0.24615039
NSC 726195 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one 0.0176693828663438 0.54540164
NSC 741440 3,3?-furan-2,5-diylbis(5-methoxy-1-methyl-1H-indole) 0.0176693828663438 -0.039153566
NSC 743915 Null 0.0176693828663438 0.15370719
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.0176693828663438 0.30054052
NSC 58239 A 80021F34 0.0181211508101517 0.533195
NSC 633203 Null 0.0181211508101517 -0.1242146
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.0181211508101517 0.25764039
Total:136  Current:54    [First] [Prev] [Next] [Last]